Syndax Pharmaceuticals and Incyte Announce Axatilimab Phase 1/2 Data in Patients with Chronic Graft-Versus-Host Disease Published in the Journal of Clinical OncologyPRNewsWire • 12/05/22
Syndax Pharmaceuticals Announces Appointment of Steve Sabus as Chief Commercial OfficerPRNewsWire • 12/02/22
Can Syndax (SNDX) Climb 39% to Reach the Level Wall Street Analysts Expect?Zacks Investment Research • 12/01/22
Syndax Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Clinical and Business UpdatePRNewsWire • 11/03/22
Syndax Announces Positive Updates to Clinical Activity and Durable Remissions in Phase 1 Portion of AUGMENT-101 Trial of Revumenib in Patients with Acute LeukemiasPRNewsWire • 11/03/22
Syndax to Announce Third Quarter 2022 Financial Results and Host Conference Call and Webcast on November 3, 2022PRNewsWire • 10/27/22
Syndax Pharmaceuticals, Inc. (SNDX) CEO Michael Metzger on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/08/22
Amphastar, Syndax Top Second-Quarter Estimates, But Runaway Biotechs At A StandstillInvestors Business Daily • 08/08/22
Syndax Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Clinical and Business UpdatePRNewsWire • 08/08/22
Syndax to Announce Second Quarter 2022 Financial Results and Host Conference Call and Webcast on August 8, 2022PRNewsWire • 08/02/22
Does Syndax (SNDX) Have the Potential to Rally 67% as Wall Street Analysts Expect?Zacks Investment Research • 08/01/22
Syndax Pharmaceuticals Announces Appointment of Keith A. Goldan as Chief Financial OfficerPRNewsWire • 06/13/22
Syndax Pharmaceuticals, Inc. (SNDX) CEO Michael Metzger on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/10/22
Syndax Pharmaceuticals (SNDX) Reports Q1 Loss, Lags Revenue EstimatesZacks Investment Research • 05/09/22
Syndax Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Clinical and Business UpdatePRNewsWire • 05/09/22
Syndax to Announce First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 9, 2022PRNewsWire • 05/02/22
Syndax Pharmaceuticals, Inc. (SNDX) CEO Michael Metzger on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/02/22
Syndax Pharmaceuticals Reports Fourth Quarter 2021 Financial Results and Provides Clinical and Business UpdatePRNewsWire • 03/01/22
Syndax Pharmaceuticals Announces Appointment of Kate Madigan, M.D., as Chief Medical OfficerPRNewsWire • 03/01/22